Skip to main content

Diabetic Renal-Retinal Syndrome

21st Century Management Now

  • Book
  • © 1998

Overview

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (20 chapters)

Keywords

About this book

After a decade or longer, approximately one-third of individuals with either type 1 or type 2 diabetes commence a downhill course in which decreasing renal function and failing vision define a Renal-Retinal Syndrome, dominating all aspects of life and presaging early death. Only a generation ago, survival after onset of end-stage renal disease (ESRD) in diabetes was limited because rehabilitation was preempted by blindness, limb amputation, stroke, and heart disease. By 1998, however, team management has improved the outlook, with preserved sight and return to work and home responsibilities, usually for a decade or longer, following kidney transplantation and laser photocoagulation. Recognition of the critical requirement for blood pressure regulation and metabolic control are central themes in management.
In this unique book, the accomplishments of ophthalmologists, nephrologists, diabetologists, transplant surgeons, and basic scientists are blended into a strategic approach that may be readily applied by all those caring for diabetic patients. Each of twenty-one presentations suitable for primary care physicians, as well as for subspecialists concerned with macrovascular and microvascular complications of diabetes, is placed in perspective by an introductory editorial analysis. Promising near-term innovative therapies, including insertion of genetically engineered beta cells or polymer-coated islets of Langerhans, interdiction of kinins that promote retinal angiogenesis, and prevention of synthesis of advanced glycosylated endproducts (AGEs), are presented in detail. While comprehensive care of diabetic patients reflects multiple incremental advances that in sum afford major benefit, this text envisions further remarkable changes likely to suppress and possibly entirely prevent the Diabetic Renal-Retinal Syndrome.

Reviews

`Altogether, the volume presents a clear overview of some aspects of teh last 20 years' improvements within prevention and treatment of diabetic complications in the kidney and in the eye. The chapters dealing with diabetic retinopathy are well written, reflecting the authors' personal iunterests.'
Acta Ophthalmologica Scandinavica (1999)

Editors and Affiliations

  • Department of Medicine, State University of New York, Health Science Center at Brooklyn, Brooklyn, USA

    Eli A. Friedman

  • College of Physicians and Surgeons, Columbia University, New York, USA

    Francis A. L’Esperance

Bibliographic Information

  • Book Title: Diabetic Renal-Retinal Syndrome

  • Book Subtitle: 21st Century Management Now

  • Editors: Eli A. Friedman, Francis A. L’Esperance

  • DOI: https://doi.org/10.1007/978-94-011-4962-4

  • Publisher: Springer Dordrecht

  • eBook Packages: Springer Book Archive

  • Copyright Information: Springer Science+Business Media Dordrecht 1998

  • Hardcover ISBN: 978-0-7923-5049-1Published: 31 July 1998

  • Softcover ISBN: 978-94-010-6083-7Published: 09 October 2012

  • eBook ISBN: 978-94-011-4962-4Published: 06 December 2012

  • Edition Number: 1

  • Number of Pages: XV, 284

  • Topics: Nephrology, Diabetes, Ophthalmology

  • Industry Sectors: Biotechnology, Health & Hospitals, Pharma

Publish with us